Radiation for High-Risk Spine Metastases
This study is looking at whether Stereotactic Body Radiation Therapy (SBRT) to the spine can be used as the main treatment for certain cancers that have spread aggressively to the spine. The goal is to help patients avoid a large spine surgery. You might be able to join if you are 18 or older, have a solid tumor cancer that has spread to your bones (not your brain or spinal cord), and have spine involvement in up to three connected spinal bones. The study will measure how many people need spinal surgery or stabilization within 6 months after receiving SBRT. The current status of this study is unclear, and it plans to enroll 26 participants.
- Study design
- This is an interventional study with a planned enrollment of 26 participants. The phase of the study is not specified.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will follow participants for 6 months to see if they need spinal surgery or stabilization.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Definitive Radiation for High-Risk Spine Metastases
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Kartik Mani, MD PhD · PRINCIPAL_INVESTIGATOR · Stony Brook Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Cumulative incidence of spinal surgery/stabilization within 6 months following SBRT6 months
Assess the efficacy of spine SBRT alone in controlling spine metastases